The cost of prescription medicines used by millions of people every day is about to plummet.
The next 14 months will bring generic versions of seven of the world’s 20 best-selling drugs, including the top two: cholesterol fighter Lipitor and blood thinner Plavix.
The magnitude of this wave of expiring drugs patents is unprecedented. Between now and 2016, blockbusters with about $255 billion in global annual sales are set to go off patent, notes EvaluatePharma Ltd., a London research firm. Generic competition will decimate sales of the brand-name drugs and slash the cost to patients and companies that provide health benefits.
Top drugs getting generic competition by September 2012 are taken by millions every day: Lipitor alone is taken by about 4.3 million Americans and Plavix by 1.4 million. Generic versions of big-selling drugs for blood pressure, asthma, diabetes, depression, high triglycerides, HIV and bipolar disorder also are coming by then.
The flood of generics will continue for the next decade or so, as about 120 brand-name prescription drugs lose market exclusivity, according to prescription benefit manager Medco Health Solutions Inc.
For original article, Click here. Linda A. Johnson
J. Kyle Mathews, MD
Plano OBGyn Associates
Plano Urogynecology Associates
Tags: asthma, benefit, blood pressure, Dr. Mathews, Drug prices, HIV, kyle mathews, London, Medco Health Solutions Inc, Patents | Category: News & Education |